Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.37 |
| ▸ | PRKACA | P17612 | 2/20 | 0.36 |
| ▸ | PRKACG | P22612 | 2/20 | 0.36 |
| ▸ | PRKACB | P22694 | 2/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.34 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.34 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.34 |
| ▸ | PDE4A | P27815 | 2/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.33 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29516001 | 0.91 | STING1 (0.36) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL29515889 | 0.91 | RXFP1 (0.46) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL22589417 | 0.83 | RXFP1 (0.42) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL29516128 | 0.81 | STING1 (0.39) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL18720671 | 0.75 | RXFP1 (0.45) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL30087472 | 0.73 | STING1 (0.43) | STING1 | |
| SCHEMBL29516378 | 0.71 | STING1 (0.35) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL18720673 | 0.70 | RXFP1 (0.39) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL29516258 | 0.69 | RXFP1 (0.44) | RXFP1STING1PRKACAPRKACGPRKACB | |
| SCHEMBL30087410 | 0.69 | STING1 (0.41) | STING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4232456-A1 | ANTIVIRAL PRODRUG COMPOUNDS | Ligand Pharmaceuticals, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| WO-2022086958-A1 | ANTIVIRAL PRODRUG COMPOUNDS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2022-04-28 | — | — | WO | disclosed |